首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 生物科技 > 生技設備 > 全球的基因增幅技術市場
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

全球的基因增幅技術市場

Gene Amplification Technologies

出版商 Global Industry Analysts, Inc.
出版日期 2011年01月 商品編碼 169836
內容資訊 英文 Pages: 466
價格
本報告書已不再販售

本報告已在2012年04月11日停止出版。

更改為出版

遺傳基因放大技術的全球市場
Gene Amplification Technologies
出版日期 : 2012年02月
商品編碼: 236737

簡介

本報告書內容包括:全球的基因增幅技術市場的解說、產品及技術概要、使用者市場趨勢、近年的業界活動、以及主要企業的介紹等、各國市場的趨勢、內容綱要摘記如下:

第1章 介紹、方法論、產品的定義

第2章 業界概要

  • PCR佔有增幅技術
  • 小型化：新一代為焦點
  • 診斷順序的相關議論
  • 主要企業

第3章 技術概要

  • 基因增幅的定義
  • 標的對信號增幅
  • 可得手的基因增幅技術的種類

第4章 使用者市場分析

  • 醫療及診斷
  • 法醫學和父子鑑定
  • 食品安全

第5章 產品革新／上市

第6章 近年的產品引進・上市

第7章 近年的業界活動

第8章 近年的企業活動

第9章 主要企業介紹

  • Abbott Laboratories（美國）
  • Applied Biosystems（美國）
  • Becton, Dickinson and Company（美國）
  • bioMerieux （法國）
  • Bio-Rad Laboratories（美國）
  • Cepheid （美國）
  • Life Technologies corp.（美國）
  • QIAGEN N.V （荷蘭）
  • Roche Diagnostics （瑞士）
  • Rubicon Genomics （美國）
  • Takara Bio, Inc.（日本）

第10章 全球市場展望

第11章 美國

第12章 加拿大

第13章 日本

第14章 歐洲

第15章 其他各國

企業介紹：91家

目錄

Abstract

This report analyzes the worldwide markets for Gene Amplification Technologies in US$ Million by the following Product segments: Polymerase Chain Reaction, and Other Gene Amplification Technologies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets.The report profiles 91 companies including many key and niche players such as Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Cepheid, Life Technologies Corp., QIAGEN N.V, Roche Diagnostics, Rubicon Genomics, and Takara Bio, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

  • Study Reliability and Reporting Limitations 1
  • Disclaimers 2
  • Data Interpretation & Reporting Level 2
    • Quantitative Techniques & Analytics 3
  • Product Definitions and Scope of Study 3
    • Definitions 3
    • Polymerase Chain Reaction 3
    • Other Gene Amplification Technologies 3

2. INDUSTRY OVERVIEW 4

  • PCR Dominates Amplification Technologies 4
  • Miniaturization - The Next Big Focus 4
  • Critical in Diagnostic Procedures 5
  • Leading Players 5

3. TECHNOLOGY OVERVIEW 6

  • Definition of Gene Amplification 6
  • Target vs. Signal Amplification 6
  • Available Types of Gene Amplification Technologies 6
    • Polymerase Chain Reaction 6
    • Reagents and Equipment required for PCR 7
    • Reaction Steps 7
    • Denaturation 7
    • Annealing 7
    • Extension 7
    • Detection of Amplified Product/DNA 8
    • (Q&Q) PCR 8
    • Reverse Transcriptase PCR (RT-PCR) 9 Alternative Technologies to PCR 9
    • OmniPlex 9
    • Strand Displacement Amplification 10
    • Ligase Chain Reaction 10
    • LCR Involves a Cyclic Two-Step Reaction 10
    • Gene Amplification Technology (GAT) 10
    • Hybrid Capture 10
    • Isothermal DNA Amplification Techniques 11
    • Rolling circle Amplification in Diagnostics 11
    • Ican Isothermal Gene Amplification Technology 11
    • BioHelix HDA Technology 11
    • Other Amplification Technologies 11
    • Signal Amplification Technology 11
    • Transcription Mediated Amplification 12
    • DNA cleavage-based signal amplification 12
    • Ramification Amplification Method 12

4. END USE MARKET ANALYSIS 13

  • Medical and Diagnostics 13
    • Role of Amplification Technology in the Diagnoses of Infectious Diseases 13
    • Diagnosis of Infectious Diseases by PCR 13
    • Detection of Antimicrobial Resistance 14
    • PCR Based Nucleic Acid Amplification for Detection of Antimicrobial Agents 14
    • Nucleic Acid Amplification Testing (NAT) 14
    • Nucleic Acid Amplification Methods 15
    • DNA Amplification Technology in the Diagnosis of Infectious Diseases 15
  • Forensic and Paternity Testing 15
  • Food Safety 16

5. PRODUCT INNOVATIONS/LAUNCHES 17

  • DuPont Qualicon Launches New BAX(r) System Real-Time PCR Assay 17
  • Rubicon Genomics Launches PicoPlex Single Cell WGA Kit 17
  • NuGEN Unveils WT-OvationTM RNA Amplification System for Whole-Transcriptome Gene Expression Analysis 17
  • DuPont Qualicon Obtains Approval from Russian Federal Consumer Rights Protection and Human Health Control Service for BAX(tm) System 18
  • DuPont Qualicon Receives Approval from the General Administration of Quality Supervision, Inspection and Quarantine for BAX(r) system 18
  • Seegene Enters into Partnership with Shimadzu 19
  • Bio-Rad Launches New CFX96 PCR Detection System 19

6. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER 20

  • Roche Introduces Genome Sequencer FLX System 20
  • QIAGEN Launches TopTaq DNA Polymerase 20
  • Applied Biosystems Introduces TaqMan Array Human MicroRNA Panel 20
  • Spartan Introduces Spartan DX 21
  • Applied Biosystems Launches Forensic Tools 21
  • Applied Biosystems Introduces StepOne Real-Time PCR System 21
  • Sigma-Aldrich Unveils GenomePlex Tissue Whole Genome Amplification Kit 22
  • QIAGEN Rolls Out Wide RNAi and SYBR(r) Green-based RT- PCR 22
  • Applied Biosystems Launches 7500 Fast Real-Time PCR System 22
  • Applied Biosystems Launches 9800 Fast PCR System 23
  • 7900HT Fast Real-Time PCR System from Applied Biosystems 23
  • Enzo Life Sciences Introduces New Advanced Amplification Technology 23
  • Applied Biosystems Unveils AmpFSTR(r) Yfiler(tm) PCR Amplification Kit 24
  • Amersham Launches GenomiPhi 24
  • Rubicon Genomics Launches GenomePlex WGA 24
  • Agilent Introduces Amplification Kit 24
  • Linden Introduces Snapshot mRNA 25
  • Rubicon Launches OmniPlex(tm) 25

7. RECENT INDUSTRY ACTIVITY 26

  • QIAGEN Acquires Rights to 70 Molecular Food Safety Tests from ifp 26
  • Life Technologies to Acquire Geneart 26
  • Thermo Fisher Scientific Takes Over Finnzymes 26
  • Abbott Inks Agreement with GlaxoSmithKline for Developing Molecular Diagnostic Test 26
  • DXS Purchases License for P13K Gene from Johns Hopkins University 27
  • Qiagen Acquires SABiosciences 27
  • DuPont Qualicon Obtains License from DxS for Scorpions(r) Technology 27
  • BD Takes Over HandyLab 28
  • Life Technologies Takes Over BioTrove 28
  • Merck Merges with Schering-Plough 28
  • QIAGEN Acquires Licenses from Idaho Technology and Roche 28
  • Response Genetics Inks Non-Exclusive Agreement with Roche Diagnostics 29
  • Invitrogen Announces Merger with Applied Biosystems 29
  • Hologic Acquires Third Wave Technologies 29
  • BIOTECON Acquires Roche' s Technology License 29
  • QIAGEN Signs a Global Licensing Agreement with BioHelix 30
  • BioTrove and Gene Express Receive NIH Grant for Innovative Bio-experimentation 30

8. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER 31

  • SuperArray Bioscience Inks License Agreement with Applied Biosystems 31
  • Merck Capital Takes Over Minority Interest in High Throughput Genomics 31
  • NuGEN Enters into a Service Agreement with ExonHit 31
  • Qiagen Enters into License Agreements with Roche and Ortho-Clinical 32
  • Agilent Takes Over Stratagene 32
  • Eiken Chemical Inks Licensing Agreement with Meridian Bioscience 32
  • Sigma-Aldrich Acquires JRH 33
  • Sigma-Aldrich Snaps Up Proligo 33
  • Beckman Acquires Agencourt 33
  • Roche Diagnostics and Applera Corporation Expand PCR Licensing Program 33
  • Mount and Hamilton Receive Patent 33
  • Invitrogen Bags License from Applied Biosystems 33
  • OriGene to Access TrueClone 34
  • Orchid BioSciences to Turn into Orchid Cellmark 34
  • QIAGEN Purchases Assets of Molecular Staging 34
  • Cepheid, Applied Biosystems and Celera Diagnostics Sign Patent License Agreement 34
  • Abbott Enters into Agreement with BioGenex 35
  • Roche Inks Licensing Agreement with Incyte Corp 35
  • Rubicon Genomics Signs Licensing Agreement with Sigma-Aldrich 35
  • BioMérieux Teams-up with Cepheid 35
  • Molecular Staging Collaborates with Eli Lilly 35
  • Pacific Biometrics Inc. Receives Gene Amplification Patent 35
  • Rubicon Introduces Service for Genome Amplification 36
  • Takara Obtains Patent for New Amplification Method 36

9. FOCUS ON SELECT GLOBAL PLAYERS 37

  • Abbott Laboratories (US) 37
  • Becton, Dickinson and Company (US) 37
  • bioMérieux (France) 37
  • Bio-Rad Laboratories (US) 38
  • Cepheid (US) 38
  • Life Technologies Corp. (US) 38
  • QIAGEN N.V. (The Netherlands) 39
  • Roche Diagnostics (Switzerland) 39
  • Rubicon Genomics (US) 40
  • Takara Bio, Inc. 40

10. GLOBAL MARKET PERSPECTIVE 41

  • Table 1: World Recent Past, Current & Future Market Analysisfor Gene Amplification Technologies by Geographic Region -US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2007 through 2015(includes corresponding Graph/Chart) 41
  • Table 2: World Historic Review for Gene Amplification Technologies by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2000through 2006 (includes corresponding Graph/Chart) 42
  • Table 3: World 11-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan, Europe, andRest of World Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart) 43
  • Table 4: World Recent Past, Current & Future Market Analysisfor Polymerase Chain Reaction (PCR) by Geographic Region -US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2007 through 2015 (includescorresponding Graph/Chart) 44
  • Table 5: World Historic Review for Polymerase ChainReaction (PCR) by Geographic Region - US, Canada,Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2000 through 2006 (includes corresponding Graph/Chart) 45
  • Table 6: World 11-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - PercentageBreakdown of Dollar Sales for US, Canada, Japan, Europe,and Rest of World Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart) 46
  • Table 7: World Recent Past, Current & Future Market Analysisfor Other Gene Amplification Technologies by GeographicRegion - US, Canada, Japan, Europe, and Rest of WorldMarkets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2007 through 2015(includes corresponding Graph/Chart) 47
  • Table 8: World Historic Review for Other Gene Amplification Technologies by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2000through 2006 (includes corresponding Graph/Chart) 48
  • Table 9: World 11-Year Perspective for Other GeneAmplification Technologies by Geographic Region -Percentage Breakdown of Dollar Sales for US, Canada,Japan, Europe, and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart) 49

11. THE UNITED STATES 50

  • A. Market Analysis 50
    • Real-Time PCR Market in North America: A Primer 50
    • Table 10: Leading Suppliers of Individual qPCRReagents in North America (2008): PercentageDollar Share Breakdown of Invitrogen, AppliedBiosystems, Roche Applied, Bio-Rad/ MJ, BDClontech, Promega, Amblon, NEB, Qiagen,and Others (includes correspondingGraph/Chart) 50
    • Key Factors (Ranked in Order) in Selection of Real-Time/qPCR Platforms Manufacturers 51
    • Top 10 Research Applications of Real-Time Quantitative PCR (qPCR) in North America 51
  • B. Market Analytics 52
    • Table 11: US Recent Past, Current & Future Analysisfor Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years2007 through 2015 (includes correspondingGraph/Chart) 52
    • Table 12: US Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for Years 2000 through 2006(includes corresponding Graph/Chart) 53
    • Table 13: US 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown ofDollar Sales for Polymerase Chain Reaction (PCR)and Other Gene Amplification Markets for2005, 2010 & 2015 53

12. CANADA 54

  • Market Analysis 54
    • Table 14: Canadian Recent Past, Current & FutureAnalysis for Gene Amplification Technologies bySegment - Polymerase Chain Reaction (PCR) andOther Gene Amplification Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Millionfor Years 2007 through 2015 (includescorresponding Graph/Chart) 54
    • Table 15: Canadian Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2000 through 2006 (includes corresponding Graph/Chart) 55
    • Table 16: Canadian 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 55

13. JAPAN 56

  • Market Analysis 56
    • Table 17: Japanese Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart) 56
    • Table 18: Japanese Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2000 through 2006 (includes corresponding Graph/Chart) 57
    • Table 19: Japanese 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 57

14. EUROPE 58

  • Market Analysis 58
    • Table 20: European Recent Past, Current & FutureAnalysis for Gene Amplification Technologies byGeographic Region - France, Germany, UK, Italy, andRest of Europe Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart) 58
    • Table 21: European Historic Review for GeneAmplification Technologies by Geographic Region -France, Germany, UK, Italy, and Rest of EuropeMarkets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 59
    • Table 22: European 11-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for France,Germany, UK, Italy, & Rest of Europe Marketsfor Years 2005, 2010 & 2015 (includescorresponding Graph/Chart) 60
    • Table 23: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart) 61
    • Table 24: European Historic Review for GeneAmplification Technologies by Segment - PolymeraseChain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 62
    • Table 25: European 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 62

14a. FRANCE 63

  • Market Analysis 63
    • Table 26: French Recent Past, Current & Future Analysisfor Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes correspondingGraph/Chart) 63
    • Table 27: French Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2000 through 2006 (includes corresponding Graph/Chart) 64
    • Table 28: French 11-Year Perspective for GeneAmplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 64

14b. GERMANY 65

  • Market Analysis 65
    • Table 29: German Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart) 65
    • Table 30: German Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2000 through 2006 (includes corresponding Graph/Chart) 66
    • Table 31: German 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 66

14c. ITALY 67

  • Market Analysis 67
    • Table 32: Italian Recent Past, Current & Future Analysisfor Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart) 67
    • Table 33: Italian Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2000 through 2006 (includes corresponding Graph/Chart) 68
    • Table 34: Italian 11-Year Perspective for GeneAmplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 68

14d. UNITED KINGDOM 69

  • Market Analysis 69
    • Table 35: UK Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 69
    • Table 36: UK Historic Review for Gene Amplification Technologies by Segment - Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2000 through 2006 (includes corresponding Graph/Chart) 70
    • Table 37: UK 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown ofDollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2005,2010 & 2015 70

14e. REST OF EUROPE 71

  • Market Analysis 71
    • Table 38: Rest of Europe Market for Gene Amplification Technologies - Recent Past, Current & Future Market Analysis by Segment for Polymerase Chain Reaction (PCR)and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor Years 2007 through 2015 (includescorresponding Graph/Chart) 71
    • Table 39: Rest of Europe Historic Review for Gene Amplification Technologies by Segment - PolymeraseChain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 72
    • Table 40: Rest of Europe 11-Year Perspective for Gene Amplification Technologies by Segment - Percentage Breakdown of Dollar Sales for Polymerase ChainReaction (PCR) and Other Gene AmplificationMarkets for 2005, 2010 & 2015 72

15. REST OF WORLD 73

  • Market Analysis 73
    • Table 41: Rest of World Market for Gene Amplification Technologies - Recent Past, Current & Future Market Analysis by Segment for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2007 through 2015 (includes correspondingGraph/Chart) 73
    • Table 42: Rest of World Historic Review for Gene Amplification Technologies by Segment - PolymeraseChain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 74
    • Table 43: Rest of World 11-Year Perspective forGene Amplification Technologies by Segment -Percentage Breakdown of Dollar Sales forPolymerase Chain Reaction (PCR) and OtherGene Amplification Markets for 2005,2010 & 2015 74

COMPETITIVE LANDSCAPE
Back to Top